Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 5 29-5, 2003, Pages

  Hamad, Ahmed M ^a   Clayton, Andrew ^b   Islam, Baharul ^b   Knox, Alan J ^b,c  

^a MANSOURA UNIVERSITY   (Egypt)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Asthma; Atrial natriuretic peptide; Guanosine 3 ,5 cyclic monophosphate

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE;

AIRWAY; ASTHMA; DRUG EFFECT; EVIDENCE BASED MEDICINE; HORMONE ACTION; HUMAN; MUSCLE FUNCTION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION;

EID: 0142150990     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00033.2003     Document Type: Review

References (129)

1. ca channel in airway smooth muscle by nitric oxide: involvement of a nitrothiosylation mechanism? Am J Respir Cell Mol Biol 19: 485-497, 1998.
2. Angus RM, McCallum MJA, Hulks G, and Thomson NC. Bronchodilator, cardiovascular and cGMP response to high dose infused ANP in asthma. Am Rev Respir Dis 147: 1122-1125, 1993.
3. Angus RM, McCallum MJA, and Thomson NC. Effect of inhaled ANP on methacholine-induced bronchoconstriction in asthma. Clin Exp Allergy 24: 784-788, 1994.
4. Angus RM, Millar EA, Chalmer GW, and Thomson NC. Effect of inhaled ANP and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction. Am J Respir Crit Care Med 151: 2003-2005, 1995.
5. Angus RM, Millar EA, Chalmer GW, and Thomson NC. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled ANP. Thorax 51: 71-74, 1996.
6. Angus RM, Nally JE, McCall R, Young LC, McGrath JC, and Thomson NC. Modulation of the effect of atrial natriuretic peptide in human and bovine bronchi by phosphoramidon. Clin Sci (Lond) 86: 291-295, 1994.
7. Asai J, Nakazato M, Toshimori H, Matsukura S, Kangawa K, and Matsuo H. Presence of atrial natriuretic polypeptide in the pulmonary vein and vena cava. Biochem Biophys Res Commun 146: 1465-1470, 1987.
8. Asano K, Chee CBE, Gaston B, Lilly CM, Gerard C, and Stamler JS. Constitutive and inducible NOS gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91: 10089-10093, 1994.
9. Banerjee MR and Newman JH. Acute effects of ANP on lung mechanics and hemodynamics in awake sheep. J Appl Physiol 69: 728-733, 1990.
10. Belvisi MG, Stretton CD, Miura M, Verleden GM, Tadjkarimi S, Yacoub M, and Barnes PJ. Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. J Appl Physiol 73: 2505-2510, 1992.
11. Belvisi MG, Stretton CD, Yacoub M, and Barnes PJ. NO is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 210: 221-222, 1992.
12. Bloch KD, Filippov G, Sanchez LS, Nakane M, and De La Monte SM. Pulmonary soluble guanylyl cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol Lung Cell Mol Physiol 272: L400-L406, 1997.
13. Byrick R, Hobbs E, Martineau R, and Nobel W. Nitroglycerin relaxes large airways. Anesth Analg 62: 421-425, 1983.
14. Candenas ML, Naline E, Puybasset L, Devillier P, and Advenier C. Effect of ANP and atriopeptins on the human isolated bronchus. Comparison with the reactivity of the guinea pig isolated trachea. Pulm Pharmacol 4: 120-125, 1991.
15. Cardell LO, Lou YP, Takeyama K, Ueki IF, Lausier J, and Nadel JA. Carbon monoxide, a cyclic GMP-related messenger, involved in hypoxic bronchodilation in vivo. Pulm Pharmacol 11: 309-315, 1998.
16. Cardell LO, Ueki IF, Stjarne P, Agusti C, Takeyama K, Linden A, and Nadel JA. Bronchodilatation in vivo by carbon monoxide, a cyclic GMP related messenger. Br J Pharmacol 124: 1065-1068, 1998.
17. Chanez P, Mann C, Bousquet J, and Chabrier PE. Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol 86: 321-324, 1990.
18. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, and Nathan C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176: 599-604, 1992.
19. Clayton RA, Nally JE, Thomson NC, and McGrath JC. Changing the oxygen tension alters the ability of bronchodilators to protect against methacholine-induced challenge in bovine isolated bronchial rings. Pulm Pharmacol 10: 51-60, 1997.
20. Clayton RA, Nally JE, Thomson NC, and McGrath JC. Interaction between endothelin-1 induced contraction and bronchodilators in human isolated bronchi. Clin Sci (Lond) 93: 527-533, 1997.
21. Cornwell TL, Arnold E, Boerth NJ, and Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol Cell Physiol 267: C1405-C1413, 1994.
22. Craven PA and Derubertis FR. Properties and subcellular distribution of guanylate cyclase activity in rat renal medulla: correlation with tissue content of guanosine 3′,5′-monophosphate. Biochemistry 15: 5131-5137, 1976.
23. DeJong HR. Properties of guanylyl cyclase and levels of cyclic GMP in rat small intestinal villous and crypt cells. FEBS Lett 55: 143-152, 1975.
24. Devillier P, Corompt E, Breant D, Caron F, and Bessard G. Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle. Eur J Pharmacol 430: 325-333, 2001.
25. Diamond J. Role of cGMP in airway smooth muscle relaxation. Agents Actions Suppl 43: 13-26, 1993.
26. 2+ current through a mechanism independent of cGMP-dependent protein kinase. Neuron 1: 693-699, 1998.
27. Dupuy PM, Shore SA, Drazen J, Frostell CG, Hill WA, and Zapol WM. Bronchodilator action of inhaled NO in guinea pigs. J Clin Invest 90: 421-428, 1992.
28. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, and Burnett JC. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 62: 191-195, 1988.
29. +-ATPase activity through cyclic GMP pathway in proximal rat trachea. Eur J Pharmacol 367: 307-314, 1999.
30. G-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airways. Am Rev Respir Dis 146: 1543-1547, 1992.
31. Enghlebach IM, Lappe RW, and Hand JM. Bronchoprotective and bronchodilator activity of anaritide [human atrial natriuretic factor (102-126)] infusion in the anesthetized guinea pig. Pulm Pharmacol 1: 119-123, 1988.
32. Fernandes LB, Ellis JL, and Undem BJ. Potentiation of nonadrenergic noncholinergic relaxation of human isolated bronchus by selective inhibitors of phosphodiesterase isoenzymes. Am J Respir Crit Care Med 150: 1384-1390, 1994.
33. Fernandes LB, Preuss JMH, and Goldie RG. Epithelial modulation of relaxant activity of atriopeptides in rat and guinea pig tracheal smooth muscle. Eur J Pharmacol 212: 187-194, 1992.
34. Figini M, Ricciardolo FL, Javdan P, Nijkamp FP, Emanueli C, Pradelles P, Folkerts G, and Geppetti P. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. Am J Respir Crit Care Med 153: 918-923, 1996.
35. Gardner DG, Deschepper CF, Ganong WF, Hane S, Fiddes J, Baxter JD, and Lewicki J. Extra-atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci USA 83: 6697-6701, 1986.
36. Gaston B, Drazen J, Jansen A, Sugarbaker D, Loscalzo J, Richards W, and Stamler JS. Relaxation of human smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther 268: 978-984, 1994.
37. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Billiar TR, and Snyder SH. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491-3495, 1993.
38. Goldstein JA. Nitroglycerin therapy of asthma. Chest 85: 449, 1984.
39. Gruetter CA, Kadowitz PJ, and Ignarro LJ. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrate, and amyl nitrite. Can J Physiol Pharmacol 59: 150-156, 1981.
40. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, and Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 92: 7809-7813, 1995.
41. Gutkowska G, Cantin M, Genest J, and Pierre S. Release of immunoreactive atrial natriuretic factor from the isolated perfused rat lung. FEBS Lett 214: 17-20, 1987.
42. Hamad AM, Johnson SR, and Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 277: L910-L918, 1999.
43. Hamad AM and Knox AJ. Mechanisms involved in desensitization of particulate guanylyl cyclase in human airway smooth muscle: the role of protein kinase C. Biochem Biophys Res Commun 266: 152-155, 1999.
44. Hamad AM and Knox AJ. Mechanisms mediating the anti-proliferative effects of nitric oxide in cultured human airway smooth muscle cells. FEBS Lett 506: 91-96, 2001.
45. Hamad AM, Range SP, Holland E, and Knox AJ. Regulation of cyclic GMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 273: L807-L813, 1997.
46. Hamad AM, Range SP, Holland E, and Knox AJ. Desensitization of guanylyl cyclases in cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol 20: 1087-1095, 1999.
47. Hamel R and Ford-Hutchinson AW. Relaxant profile of synthetic ANF on guinea-pig pulmonary tissues. Eur J Pharmacol 121: 151-155, 1986.
48. Hobbs AJ. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol Sci 18: 484-491, 1997.
49. Hogman M, Frostell CG, Arnberg H, and Hedenstierna G. Inhalation of NO modulates metacholine-induced bronchoconstriction in the rabbit. Eur Respir J 6: 177-180, 1993.
50. Hogman M, Frostell CG, Hedenstrom H, and Hedenstierna G. Inhalation of NO modulates adult human bronchial tone. Am Rev Respir Dis 148: 1474-1478, 1993.
51. Hulks G, Jardine A, Connell JM, and Thomson NC. Influence of elevated plasma levels of atrial natriuretic factor on bronchial reactivity in asthma. Am Rev Respir Dis 143: 778-782, 1991.
52. Hulks G, Jardine A, Connell JM, and Thomson NC. Bronchodilator effect of atrial natriuretic peptide in asthma. BMJ 299: 1081-1082, 1989.
53. Hulks G, Jardine AJ, Connell JMC, and Thomson NC. Effect of atrial natriuretic factor on bronchomotor tone in the normal human airway. Clin Sci (Lond) 79: 51-55, 1990.
54. Hulks G, Mohammed AF, Jardine A, Connell JMC, and Thomson NC. Circulating plasma concentrations of atrial natriuretic peptide and catecholamines in response to maximal exercise in normal and asthmatic subjects. Thorax 46: 824-828, 1991.
55. Hulks G and Thompson NC. High dose inhaled ANP is a bronchodilator in asthmatic subjects. Eur Respir J 7: 1593-1597, 1994.
56. Hulks G and Thomson NC. Inhaled atrial natriuretic peptide and asthmatic airways. BMJ 304: 1156, 1992.
57. Ijioma SC, Challis RAJ, and Boyle JP. Comparative effects of activation of soluble and particulate guanylyl cyclase on cGMP elevation and relaxation of bovine tracheal smooth muscle. Br J Pharmacol 115: 723-732, 1995.
58. Ishii K and Murad F. ANP relaxes bovine tracheal smooth muscle and increases cGMP. Am J Physiol Cell Physiol 256: C495-C500, 1989.
59. Jansen A, Drazen J, Osborne JA, Brown R, Loscalzo J, and Stamler JS. The relaxant properties in guinea pig airways of S-nitrosothiols. J Pharmacol Exp Ther 261: 154-160, 1992.
60. 2+. Am J Physiol Lung Cell Mol Physiol 278: L899-L905, 2000.
61. Jia L and Stamler JS. Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier. Eur J Pharmacol 366: 79-86, 1999.
62. Jiang H, Colbran JL, Francis SH, and Corbin JD. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267: 1015-1019, 1992.
63. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zappol WM, and Johnson DC. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methocholine induced bronchospasm. Am J Respir Crit Care Med 153: 128-135, 1996.
64. Kanthakumar K, Cundell DR, Johnson M, Wills PJ, Taylor GW, Cole PJ, and Wilson R. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin pyocyanin. Br J Pharmacol 112: 493-498, 1994.
65. Kawaguchi S, Uchida K, Ito T, Kozuka M, Shimonaka M, Mizuno T, and Hirose S. Immunohistochemical localization of ANP receptor in bovine kidney and lung. J Histochem Cytochem 37: 1739-1742, 1989.
66. Kennedy T, Summer WR, Sylvester J, and Robertson D. Airway response to sublingual nitroglycerin in acute asthma. JAMA 246: 145-147, 1981.
67. Kizawa Y, Ohuchi N, Saito K, Kusama T, and Murakami H. Effect of endothelin-1 and nitric oxide on proliferation of cultured guinea pig bronchial smooth muscle cells. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 128: 495-501, 2001.
68. Klinger JR, Warburton RR, Pietras LA, Smithies O, Swift R, and Hill NS. Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice. Am J Physiol Lung Cell Mol Physiol 276: L868-L874, 1999.
69. Knox AJ and Tattersfield AE. Airway smooth muscle relaxation. Thorax 50: 894-901, 1995.
70. Koesling D, Hartneck C, Humbert P, Bosserhoff A, Frank R, Schultz G, and Bohme E. The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. FEBS Lett 266: 128-132, 1990.
71. Lofton CE, Baron DE, and Oehlenschlager WF. Pulmonary atrial natriuretic peptide. In: Biological and Molecular Aspects of Atrial Natriuretic Factors, edited by Needleman P. New York: Liss, 1988.
72. Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, and Schappert T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 168: 17478-17488, 1993.
73. McAlpine LG, Hulks G, and Thomson NC. Effect of atrial natriuretic peptide given by intravenous infusion on broncho-constriction induced by ultrasonically nebulized water (FOG). Am Rev Respir Dis 146: 912-915, 1992.
74. Mehta S, Drazen JM, and Lilly CM. Endogenous NO and allergic bronchial hyperresponsiveness in guinea pigs. Am J Physiol Lung Cell Mol Physiol 273: L656-L662, 1997.
75. Mikawa K, Kume H, and Takagi K. Effect of atrial natriuretic peptide and 8-bromo cyclic guanosine monophosphate on human tracheal smooth muscle. Arzneimittelforschung 48: 914-918, 1998.
76. Miller WC and Shultz TF. Failure of nitroglycerin as a bronchodilator. Am Rev Respir Dis 120: 471, 1979.
77. Mittal CK, Braughler JM, Ichihara K, and Murad F. Synthesis of adenosine 3′,5′-monophosphate by guanylate cyclase, a new pathway for its formation. Biochim Biophys Acta 585: 333-342, 1979.
78. Miura M, Yamauchi H, Ichinose M, Ohuchi Y, Kageyama N, Tomaki M, Endoh N, and Shirato K. Impairment of neural NO-mediated relaxation after exposure in guinea pig airways in vitro. Am J Respir Crit Care Med 156: 217-222, 1997.
79. Mullershausen F, Russwurm M, Thompson WJ, Liu L, Koesling D, and Friebe A. Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J Cell Biol 155: 271-278, 2001.
80. Mulsch A, Busse R, and Bassenge E. Desensitization of guanylyl cyclase in nitrate tolerance does not impair endothelium-dependent responses. Eur J Pharmacol 158: 191-198, 1988.
81. Murad F. regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv Pharmacol 26: 19-33, 1994.
82. Nakane M, Arai K, Saheki S, Kuno T, Buechler W, and Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylyl cyclase from rat lung. J Biol Chem 265: 16841-16845, 1990.
83. Nakane M, Schmidt HHHW, Pollock JS, Forstermann U, and Murad F. Cloned human brain nitric oxide synthase expressed in human skeletal muscle. FEBS Lett 316: 175-180, 1993.
84. Nally JE, Clayton RA, Thomson NC, and McGrath JC. The interaction of α-human atrial natriuretic peptide (ANP) with salbutamol, sodium nitroprusside and isosorbide dinitrate in human bronchial smooth muscle. Br J Pharmacol 113: 1328-1332, 1994.
85. Nally JE, Doherty CC, Clayton RA, and Thomson NC. Bronchodilator and pre-protective effects of urodilatin in bovine bronchi in vitro: comparison with atrial natriuretic peptide. Br J Pharmacol 114: 1391-1396, 1995.
86. Nardo PD, Minieri M, Sampaolesi M, Carbone A, Loreni F, Samuel JL, and Lauro R. Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. Endocrinology 137: 4339-4350, 1996.
87. Nijkamp FP, van der Linde HJ, and Folkerts G. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro: role of the epithelium. Am Rev Respir Dis 148: 727-734, 1993.
88. Ohbayashi H, Suiti H, and Takagi K. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. Eur J Pharmacol 346: 55-64, 1998.
89. Ohbayashi H and Yamaki KI. Both inhalant and intravenous uroguanylin inhibit leukotriene C4-induced airway changes. Peptides 21: 1467-1472, 2000.
90. Okayama M, Sasaki H, and Takishima T. Bronchodilator effect of sublingual isosorbide dinitrate in asthma. Eur J Pharmacol 26: 151-155, 1984.
91. Pabelick CM, Warner DO, Perkins WJ, and Jones KA. S-nitrosoglutathione-induced decrease in calcium sensitivity of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 278: L521-L527, 2000.
92. Patel HJ, Belvisi MG, Yacoub MH, Chung KF, and Mitchell J. Constitutive expressions of type I NOS in human airway smooth muscle cells: evidence for an antiproliferative role. FASEB J 13: 1810-1816, 1999.
93. Pearse DB, Wagner EM, and Permutt S. Trachealis muscle cGMP is increased by stretch in anesthetized sheep (Abstract). Am J Respir Crit Care Med 155: A545, 1997.
94. Pelligrino DA and Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol 56: 1-18, 1998.
95. Perkins WJ, Pabelick C, Warner DO, and Jones KA. Cyclic GMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. Am J Physiol Cell Physiol 275: C468-C474, 1998.
96. Potvin W and Varma DR. Bronchodilator activity of atrial natriuretic peptide in guinea pigs. Can J Physiol Pharmacol 67: 1213-1218, 1989.
97. Rengasamy A, Xue C, and Johns RA. Immunohistochemical demonstration of a paracrine role of NO in bronchial function. Am J Physiol Lung Cell Mol Physiol 267: L704-L711, 1994.
98. 2+ sensitivity in airway smooth muscle. J Appl Physiol 92: 257-263, 2002.
99. Ricciardolo FL, Di Maria GU, Mistretta A, Sapienza MA, and Geppetti P. Impairment of bronchoprotection by NO in severe asthma. Lancet 350: 1297-1298, 1997.
100. Ricciardolo FL, Geppetti P, Mistretta A, Nadel JA, Sapienza MA, Bellofiore S, and Di Maria GU. Randomized double-blind placebo-controlled study of the effect of inhibition of NO synthesis in bradykinin induced asthma. Lancet 348: 374-377, 1996.
101. Ricciardolo FL, Nadel JA, Yoishihara S, and Geppetti P. Evidence for reduction of bradykinin-induced brochoconstriction in guinea-pigs by release of NO. Br J Pharmacol 113: 1147-1152, 1994.
102. Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Geller DA, and Polak JM. Expression of inducible nitric oxide synthase in human lung epithelial cells. Biochem Biophys Res Commun 203: 209-218, 1994.
103. Robichaud A, Michoud MC, Hamet P, and Du Souich P. Plasma atrial natriuretic peptide during spontaneous bronchoconstriction in asthmatics. Peptides 16: 653-656, 1995.
104. 2-agonist-induced bronchodilation in asthmatics. Pulm Pharmacol 8: 137-141, 1995.
105. Ruskoahe H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev 44: 479-602, 1992.
106. Sadeghi-Hashjin G, Folkerts G, Hendrick DJ, van de Loo PGF, van der Linde HJ, Dik IEM, and Nijkamp FP. Induction of guinea pig airway hyperresponsiveness by inactivation of guanylyl cyclase. Eur J Pharmacol 302: 109-115, 1996.
107. Sadeghi-Hashjin G, Henricks PAJ, Folkerts G, Verheyen AKCP, van der Linde HJ, and Nijkamp FP. Bovine tracheal responsiveness in vitro: role of the epithelium and nitric oxide. Eur Respir J 9: 2286-2293, 1996.
108. Sakamoto M, Nakao K, Morii A, Sugawara A, Yamada T, Itoh H, Shiono S, Saito Y, and Imura H. The lung as a possible target organ for atrial natriuretic polypeptide secreted from the heart. Biochem Biophys Res Commun 135: 515-520, 1985.
109. Sanna A, Kurtansky A, Veriter C, and Stanescu D. Bronchodilator effect of inhaled NO in healthy men. Am J Respir Crit Care Med 150: 1702-1704, 1994.
110. Saotome M, Uchida Y, Nomura A, Endo T, and Hasegawa S. Pituitary adenylate cyclase activating peptide induces cGMP-mediated relaxation in guinea pig airways. Pulm Pharmacol 11: 281-285, 1998.
111. Sarkar R and Webb RC. Does nitric oxide regulate smooth muscle cell proliferation? J Vasc Res 35: 135-142, 1998.
112. Schroeder H, Leitman DC, Bennett BM, Waldman SA, and Murad F. Nitroglycerin-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther 245: 413-418, 1988.
113. Schwede F, Maronde E, Genieser H, and Jastorff B. Cyclic nucleotide analog as biochemical tools and prospective drugs. Pharmacol Ther 87: 199-226, 2000.
114. Sirois P and Gutkowska J. Atrial natriuretic factor immunoreactivity in human fetal lung tissue and perfusates. Hypertension 11: 162-165, 1988.
115. Springall DR, Bhatnagar M, Wharton J, Hamid Q, Gulbenkian S, Hedges M, Meleagros L, Bloom SR, and Polak JM. Expression of the atrial natriuretic peptide gene in the cardiac muscle of rat extrapulmonary and intrapulmonary veins. Thorax 43: 44-52, 1988.
116. Stuart-Smith K, Warner DO, and Jones KA. The role of cyclic GMP in the relaxation to nitric oxide donors in airway smooth muscle. Eur J Pharmacol 241: 225-233, 1998.
117. Takagi K and Araki N. Relaxant effects of BNP on guinea pig tracheal smooth muscle. Clin Exp Pharmacol Physiol 20: 239-243, 1993.
118. Takagi K, Araki N, and Suzuki K. Relaxant effect of C-type natriuretic peptide on guinea-pig tracheal smooth muscle. Arzneimittelforschung 42: 1329-1331, 1992.
119. Tamaoki J, Nakata J, Kawatani K, Tagaya E, and Nagai A. Ginsenoside-induced relaxation of human bronchial smooth muscle via release of nitric oxide. Br J Pharmacol 130: 1859-1864, 2000.
120. Torphy TJ. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157: 351-370, 1998.
121. Tullett WM and Patel KR. Isosorbide dinitrate and isoxsuprine in exercise-induced asthma. Br Med J 280: 1934-1935, 1983.
122. Waldman SA, Rapoport RM, Ginsburg RM, and Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 35: 3523-3531, 1986.
123. Ward JK, Barnes PJ, Springall DR, Abelli L, Tadjkarimi S, Yacoub M, Polak JM, and Belvisi MG. Distribution of human i-NANC broncodilator and NO-immunoreactive nerves. Am J Respir Cell Mol Biol 13: 175-184, 1995.
124. Ward JK, Barnes PJ, Tadjkarimi S, Yacoub M, and Belvisi MG. Evidence for the involvement of cGMP in neural bronchodilator responses in human trachea. J Physiol 483: 525-536, 1995.
125. Watanabe H, Suzuki K, Takagi K, and Satake T. Mechanism of atrial natriuretic peptide and sodium nitroprusside-induced relaxation in guinea-pig tracheal smooth muscle. Arzneimittelforschung 40: 771-776, 1990.
126. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, and Thompson PJ. Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol 16: 629-639, 1997.
127. Yalkut D, Lee LY, Grider J, Jorgensen M, Jackson B, and Ott C. Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J Lab Clin Med 128: 322-328, 1996.
128. Yoshihara S, Nadel JA, Figini M, Emanueli C, Pradelles P, and Geppetti P. Endogenous nitric oxide inhibits broncho-constriction induced by cold-air inhalation in guinea pigs. Am J Respir Crit Care Med 157: 547-552, 1998.
129. Zhou H and Torphy TJ. Relationship between cGMP accumulation and relaxation of canine trachealis induced by nitro-vasodilators. J Pharmacol Exp Ther 258: 972-978, 1991.